SCM
RPTP

Sterling Capital Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Sterling Capital Management’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-12,000
Closed -$126K – 1034
2014
Q4 		$126K Buy
+12,000
New +$117K ﹤0.01% 897

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sterling Capital Management's RPTP Position: Q1 2015 in Review

Sterling Capital Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q1 2015, closing a stake of 12,000 shares — an estimated $126K sold.

Sterling Capital Management first reported a position in RPTP in Q4 2014 and held it in 1 quarter. The position peaked at $126K in Q4 2014. 75 funds tracked by Wall St. Rank hold RPTP as of Q1 2015.

  • Sterling Capital Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Sterling Capital Management sold 12,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q1 2015, an estimated $126K.
  • Sterling Capital Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2014 and held it in 1 quarter.
  • Sterling Capital Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $126K in Q4 2014.
  • 75 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q1 2015.

Based on Sterling Capital Management's 13F filing for Q1 2015, filed 19 May 2015.